Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain tumor insomnia targeted by CBT in new pilot study

NCT ID NCT06439420

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 26 times

Summary

This study tested a type of talk therapy called Cognitive Behavioral Therapy for Insomnia (CBT-I) in 70 people with brain tumors who also had trouble sleeping. The therapy involved six weekly group sessions delivered online. The main goal was to see if the approach was practical and acceptable for this group, and to explore whether it might improve sleep and well-being.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Virginia Commonwealth University

    Richmond, Virginia, 23298, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Cognitive Behavioral Therapy for Insomnia (CBT-I)

What this could lead to

If this works, it could offer a safe, non-drug way to improve sleep and quality of life for brain tumor patients.

What could go wrong

This is a small pilot study (70 people) focused on feasibility, not proof of effectiveness. Results may not apply to all brain tumor patients.

Conditions

The condition(s) this trial relates to.

astrocytoma (excluding glioblastoma) brain cancer glioblastoma glioma insomnia lymphoma meningioma oligodendroglioma primary brain neoplasm primary central nervous system lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.